Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers-Reference-Cited by-同舟云学术

Comparison of the pharmacokinetics and pharmacodynamic profile of carumonam in cystic fibrosis patients and healthy volunteers

Published:2009-10 Issue:2 Volume:65 Page:130-141
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Bulitta Jürgen B.,Duffull Stephen B.,Landersdorfer Cornelia B.,Kinzig Martina,Holzgrabe Ulrike,Stephan Ulrich,Drusano George L.,Sörgel Fritz

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference57 articles.

1. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients;Al-Aloul;J. Cyst. Fibros.,2007

2. Mechanism-based concepts of size and maturity in pharmacokinetics;Anderson;Annu. Rev. Pharmacol. Toxicol.,2008

3. NONMEM users guides;Beal,1999

4. Pharmacokinetics of carumonam after single and multiple 1- and 2-g dosage regimens;Berube;Antimicrob. Agents Chemother.,1988

5. Pharmacodynamic comparison of cystic fibrosis patients and healthy volunteers by population pharmacokinetics (PK) and Monte Carlo simulation. Poster W4056;Bulitta,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Five-Membered Heterocycles in the Molecular Structure of Antibacterial Drugs Used in Therapy;Pharmaceutics;2023-10-29

2. Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses;Clinical Pharmacokinetics;2021-01-15

3. Pharmacokinetics in Patients with Cystic Fibrosis: A Systematic Review of Data Published Between 1999 and 2019;Clinical Pharmacokinetics;2020-08-18

4. Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics;Pharmaceutics;2019-07-10

5. Novel Population Pharmacokinetic Approach to Explain the Differences between Cystic Fibrosis Patients and Healthy Volunteers via Protein Binding;Pharmaceutics;2019-06-18